General Information of Drug Transporter (DT)
DT ID	DTD0246 Transporter Info
Gene Name	SLC28A3
Protein Name	Concentrative Na(+)-nucleoside cotransporter 3
Gene ID	64078
UniProt ID	Q9HAS3
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism	rs4877847
Site of GPD	chr9:84331502 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	A>C
Minor Allele Frequency	C=0.4860/2434 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele C)		[ 1]
Doxorubicin	Drug Info	Neoplasm	Irrelevant to the likelihood of cardiotoxicity in patients (compare with Allele C)		[ 1]
Anthracyclines	N.A.	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 2]
Genetic Polymorphism	rs7853758
Site of GPD	chr9:84286011 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.2027/1015 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            2 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Doxorubicin	Drug Info	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Genetic Polymorphism	rs885004
Site of GPD	chr9:84294635 (GRCh38.p12)
GPD Type	SNP
Allele(s) in dbSNP	G>A
Minor Allele Frequency	A=0.1320/661 (Global)
Allele A	Click to Show/Hide the Full List of Affected Drugs:            3 Drugs in Total
Daunorubicin	Drug Info	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Doxorubicin	Drug Info	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 1]
Anthracyclines	N.A.	Neoplasm	Correlated with the decreased likelihood of cardiotoxicity in patients (compare with allele C)		[ 2]
References
1	Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr Blood Cancer. 2013 Aug;60(8):1375-81.
2	Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol. 2012 May 1;30(13):1422-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.